Skip to main content
Careers
Contact us
Company
About Us
Management
Board of Directors
Advisory Board
Therapeutic Focus
Neurological Disorders
Chronic Pain
Hair Loss Disorders
Science and Technology
Exicure's Approach
References and Papers
Pipeline
Pipeline
Collaboration Programs
Partnering and Licensing
Investors
Investors
News
Events & Presentations
Stock Info
Stock Quote & Chart
Analyst Coverage
Form 8937
Financials
Interactive Financials
Financial Summary
SEC Filings
Annual Reports
Governance
Executive Management
Board of Directors
Governance Documents
Committee Composition
Resources
Contact IR
FAQs
Email Alerts
News
Company
About Us
Management
Board of Directors
Advisory Board
Scientific Team
Therapeutic Focus
Genetic Disorders
Oncology
Science and Technology
Pipeline
Pipeline
AST-008
XCUR-FXN
Collaboration Programs
Compassionate Use Policy
Partnering and Licensing
Investors
Investors
News
Events & Presentations
Stock Info
Stock Quote & Chart
Analyst Coverage
Form 8937
Financials
Interactive Financials
Financial Summary
SEC Filings
Annual Reports
Governance
Executive Management
Board of Directors
Governance Documents
Committee Composition
Resources
Contact IR
FAQs
Email Alerts
Normal
Press release year list
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
12/17/2018
Exicure Announces Top-line Patient Data for Phase 1 Inflammation Program in Psoriasis
Download
PDF format download (opens in new window)
11/07/2018
Exicure Announces November 2018 Investor and Scientific Conference Schedule
Download
PDF format download (opens in new window)
11/06/2018
Exicure, Inc. Provides Update on Corporate Progress and Third Quarter 2018 Financial Results
Download
PDF format download (opens in new window)
10/02/2018
Exicure Presents First Data Demonstrating Both Oral Delivery and Liver Delivery of Spherical Nucleic Acid Constructs in Animal Models
Download
PDF format download (opens in new window)
10/01/2018
Data on Exicure’s TLR9 Agonist Spherical Nucleic Acid (SNA™) Construct Presented at the 4th CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
Download
PDF format download (opens in new window)
09/28/2018
Exicure, Inc. to Present at Upcoming Investor Conference and Participate in Oncology Roundtable
Download
PDF format download (opens in new window)
09/20/2018
Exicure Announces Positive Phase 1 Results for its Lead Immuno-Oncology Asset
Download
PDF format download (opens in new window)
08/22/2018
Exicure, Inc. Announces Expected Closing of Approximately $22 Million Private Placement Offering
Download
PDF format download (opens in new window)
08/06/2018
Exicure, Inc. Provides Update on Corporate Progress and Second Quarter 2018 Financial Results
Download
PDF format download (opens in new window)
06/15/2018
Exicure, Inc. to Present at the 2018 JMP Securities Life Sciences Conference on June 21st at 11:00 a.m. EDT
Download
PDF format download (opens in new window)
06/14/2018
Exicure to Present Data at the Cure Spinal Muscular Atrophy Annual Conference in Dallas
Download
PDF format download (opens in new window)
06/04/2018
Exicure, Inc. to Present at Jefferies 2018 Healthcare Conference on June 8th at 2:30 p.m. EDT
Download
PDF format download (opens in new window)
05/23/2018
Exicure, Inc. To Begin Trading on United States OTCQB® Under the Symbol “XCUR”
Download
PDF format download (opens in new window)
05/15/2018
Exicure, Inc. Reports First Quarter 2018 Financial Results and Reviews Corporate Progress
Download
PDF format download (opens in new window)
04/30/2018
Exicure Announces Data for Topical Anti-TNF Compound AST-005 in Patients with Mild to Moderate Psoriasis
Download
PDF format download (opens in new window)
04/24/2018
Exicure Announces Chief Executive Officer, Dr. David Giljohann, Named to Endpoints News’ “Under-40s” Biopharma Executives List
Download
PDF format download (opens in new window)
04/20/2018
Exicure Expands Leadership Team with Appointment of TLR9 Oncology Expert Matthias Schroff as Chief Operating Officer
Download
PDF format download (opens in new window)
04/16/2018
Exicure to Present Data at the American Association for Cancer Research (AACR) 2018 Annual Meeting
Download
PDF format download (opens in new window)
03/09/2018
Exicure, Inc. Reports Full Year 2017 Financial Results and Corporate Progress
Download
PDF format download (opens in new window)
01/31/2018
Exicure to Present at BIO CEO & Investor Conference, Immuno-Oncology 360° Summit and LEERINK Partners 7th Annual Global Healthcare Conference
Download
PDF format download (opens in new window)
01/05/2018
Exicure, Inc. to Present at Biotech Showcase 2018
Download
PDF format download (opens in new window)